<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Starlims Technologies Ltd</title>
	<atom:link href="http://www.stockbloghub.com/tag/starlims-technologies-ltd/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Thu, 24 May 2012 23:16:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(LIFE) Life Technologies Corporation Beats Expectations &#8211; Outlook Positive</title>
		<link>http://www.stockbloghub.com/2010/01/28/life-life-technologies-corporation-beats-expectations-outlook-positive/26320</link>
		<comments>http://www.stockbloghub.com/2010/01/28/life-life-technologies-corporation-beats-expectations-outlook-positive/26320#comments</comments>
		<pubDate>Thu, 28 Jan 2010 20:30:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Danaher Corporation]]></category>
		<category><![CDATA[DHR]]></category>
		<category><![CDATA[LIFE]]></category>
		<category><![CDATA[Life Technologies Corporation]]></category>
		<category><![CDATA[LIMS]]></category>
		<category><![CDATA[Starlims Technologies Ltd]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=26320</guid>
		<description><![CDATA[Life Technologies Corporation (LIFE) reported fourth quarter earnings of 80 cents per share, well above the Zacks Consensus Estimate of 72 cents. The company reported earnings of 82 cents in the year-ago period. For the full year, Life reported earnings of $3.04, beating the Zacks Consensus Estimate of $2.96. Full year results were better than the year-ago earnings of $2.85. Strong growth in Europe, Asia-Pacific, the Americas and Japan helped fourth quarter revenues increase 14% to $874 million. Excluding the impact of currency and the divested Lab Information Management Software (LIMS) business, revenues grew 11%. Full year revenues increased 5% to $3.3 billion. All revenue segments at Life recorded an increase in sales during the fourth quarter. The Molecular Biology Systems division recorded a 19% increase in fourth quarter revenues, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/28/life-life-technologies-corporation-beats-expectations-outlook-positive/26320/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ABT) Abbott Laboratories Aquires Starlims Technologies</title>
		<link>http://www.stockbloghub.com/2009/12/15/abt-abbott-laboratories-aquires-starlims-technologies/22922</link>
		<comments>http://www.stockbloghub.com/2009/12/15/abt-abbott-laboratories-aquires-starlims-technologies/22922#comments</comments>
		<pubDate>Wed, 16 Dec 2009 05:36:32 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Manufacturers - Major]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[LIMS]]></category>
		<category><![CDATA[Starlims Technologies Ltd]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=22922</guid>
		<description><![CDATA[Abbott Laboratories (ABT) continues to be in acquiring mode with the company recently announcing that it intends to acquire Starlims Technologies (LIMS) for $123 million in cash. Starlims is a leading provider of laboratory information management systems. It improves the reliability of laboratory sampling processes, supports compliance with domestic and international regulations and industry standards, and provides comprehensive reporting, monitoring and analysis capabilities. The software is used to manage laboratory testing. This acquisition should help Abbott strengthen its position in the global diagnostic testing market. Under the terms of the agreement, Abbott will acquire Starlims for $14 per share. Starlims currently has about $18 million in cash on hand. The transaction, scheduled to close in the first quarter of 2010, will not affect Abbott’s earnings guidance for 2009. The company ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/15/abt-abbott-laboratories-aquires-starlims-technologies/22922/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

